您的位置: 首页 > 农业专利 > 详情页

Compounds derived from furo [3,2-d] pyrimidine and its salts; a Pharmaceutical composition that comprises; and its use to treat a condition that is mediated by the activity of a protein kinase, such as cancer, cardiovascular disorders, and CNS and Immune related diseases Institute Unodeficiencia learned.
专利权人:
ABBVIE INC.
发明人:
CLAPHAM, BRUCE,CALDERWOOD, DAVID, J.,WILSON, NOEL S.,COX, PHILIP,HOEMANN, MICHAEL, Z.,MULLEN, KELLY, D.,VASUDEVAN, ANIL,VILLAMIL, CLARA I.,LI, BIN,SOMAL, GAGANDEEP
申请号:
CL2013000933
公开号:
CL2013000933A1
申请日:
2013.04.05
申请国别(地区):
CL
年份:
2014
代理人:
摘要:
The present invention is directed to novel compounds of Formula (I) pharmaceutically acceptable salts, biologically active metabolites, pro-drugs, racemates, enantiomers, diastereomers, solvates and hydrates thereof wherein the variables are defined as herein. The compounds of Formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases and proliferative disorders and conditions, for example, cancers.COMPUESTOS DERIVADOS DE FURO[3,2-D]PIRIMIDINA Y SUS SALES; COMPOSICION FARMACEUTICA QUE LOS COMPRENDE; Y SU USO PARA TRATAR UNA AFECCION QUE ESTA MEDIADA POR LA ACTIVIDAD DE UNA PROTEINA QUINASA, TAL COMO CANCER, TRASTORNOS CARDIOVASCULARES, DEL SNC E INMUNES, Y ENFERMEDADES RELACIONADAS CON LA INMUNODEFICIENCIA ADQUIRIDA.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充